Position in LLY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$14,504,708
+$6,271,847 QoQ
Shares Held
12,093
+35.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.79%
of 13F equity value
Holder Rank
#1,050
of 4,605 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 4%
Shared 0%
None 96%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DILLON & ASSOCIATES INC holds $27,210,293 across 6 Drug Manufacturers - General names. LLY ranks #1 (53.3% of the industry book) .
All Filings in LLY
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,504,708 | 12,093 | Shares | Other | 2026-08-05 | |
| 2026-03-31 | $8,232,861 | 8,951 | Shares | Other | 2026-05-07 | |
| 2025-12-31 | $7,642,050 | 7,111 | Shares | Other | 2026-02-09 | |
| 2025-09-30 | $4,557,399 | 5,973 | Shares | Other | 2025-10-28 | |
| 2025-06-30 | $3,295,852 | 4,228 | Shares | Other | 2025-08-05 | |
| 2025-03-31 | $2,082,945 | 2,522 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $961,912 | 1,246 | Shares | Other | 2025-02-11 | |
| 2024-09-30 | $400,444 | 452 | Shares | Other | 2024-11-05 | |
| 2024-06-30 | $409,231 | 452 | Shares | Other | 2024-08-06 | |
| 2024-03-31 | $351,637 | 452 | Shares | Other | 2024-04-30 | |
| 2023-12-31 | $263,479 | 452 | Shares | Other | 2024-02-08 | |
| 2023-09-30 | $252,988 | 471 | Shares | Other | 2023-11-13 | |
| 2023-06-30 | $211,509 | 451 | Shares | Other | 2023-08-08 | |
| No filing history on record for this holder in this stock. | ||||||